Business Context and Reporting Period
This Form 8-K is a current report filed by OncoGenex Pharmaceuticals, Inc. (noted as "ACHIEVE LIFE SCIENCES, INC." in metadata) on June 26, 2009. The filing addresses Item 8.01 (Other Events) regarding the issuance of a press release announcing the filing of a Shelf Registration Statement.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate event rather than a financial statement.
Material Changes
The material event reported is the filing of a Shelf Registration Statement with the SEC. This action typically allows the company to offer and sell securities in the future without filing a new registration statement for each offering, subject to market conditions.
Guidance, Outlook, and Risks
The filing incorporates a press release (Exhibit 99.1) by reference but does not contain specific management commentary, financial guidance, or a detailed discussion of risks within the body of this 8-K. The primary purpose is to notify the market of the registration filing.
Key Facts for Investor Verification
- Verify the details of the Shelf Registration Statement referenced in the press release (Exhibit 99.1) to understand the potential size and type of securities to be offered.
- Confirm the company's current cash position and capital needs, as shelf filings often precede capital raises.
- Note the discrepancy between the metadata company name ("ACHIEVE LIFE SCIENCES, INC.") and the registrant name in the document ("ONCOGENEX PHARMACEUTICALS, INC.").